Advancements in Sickle Cell Disease Advocacy and Policy: A Transformative YearAddressing these barriers to SCD care has become a priority as awareness increases. 3884/S.1852): This bipartisan bill seeks to reauthorize the HRSA Sickle Cell Disease Treatment Demonstration Program from 2024 through 2028. “We also need to help frontline sickle cell providers that treat sickle cell warriors to understand the therapy and position those providers to give evidence-informed information to the sickle cell community. Sickle Cell Disease News. Sundd P. Addressing the healthcare challenges and disparities among sickle cell disease patients.

Source: New York Times June 19, 2024 13:04 UTC